China has issued record fines of 670 million yuan ($108 million) to six baby formula companies following an anti-trust probe, the country's top economic planner announced Wednesday.
The six companies are Biostime, Mead Johnson, Dumex, Abbott, Friesland and Fonterra, said the National Development and Reform Commission (NDRC), reported Xinhua.
Biostime was fined 163 million yuan, or six percent of its sales revenue in 2012, as it "seriously violated the anti-monopoly law and failed to actively take corrective action", said Xu Kunlin, chief of the price department of the NDRC.
Mead Johnson was fined 204 million yuan, or four percent of its revenue last year, because it "did not actively cooperate with the investigation but did take active self-rectification measures".
Dumex, Abbott, Friesland and Fonterra each received a fine equal to three percent of their 2012 revenue. They were fined 172 million yuan, 77 million yuan, 48 million yuan and 4 million yuan, respectively.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
